BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 20440544)

  • 1. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
    Radisky ES; Radisky DC
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):201-12. PubMed ID: 20440544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
    Taylor MA; Parvani JG; Schiemann WP
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs and EMT in mammary cells and breast cancer.
    Wright JA; Richer JK; Goodall GJ
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):213-23. PubMed ID: 20499142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ErbB/EGF signaling and EMT in mammary development and breast cancer.
    Hardy KM; Booth BW; Hendrix MJ; Salomon DS; Strizzi L
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):191-9. PubMed ID: 20369376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
    Micalizzi DS; Farabaugh SM; Ford HL
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.
    Godde NJ; Galea RC; Elsum IA; Humbert PO
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):149-68. PubMed ID: 20461450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.
    Creighton CJ; Chang JC; Rosen JM
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):253-60. PubMed ID: 20354771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression.
    de Herreros AG; Peiró S; Nassour M; Savagner P
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):135-47. PubMed ID: 20455012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-to-mesenchymal transitions and circulating tumor cells.
    Bonnomet A; Brysse A; Tachsidis A; Waltham M; Thompson EW; Polette M; Gilles C
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):261-73. PubMed ID: 20449641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail.
    Cichon MA; Radisky DC
    Oncotarget; 2014 May; 5(9):2827-38. PubMed ID: 24811539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary gland studies as important contributors to the cause of epithelial mesenchymal plasticity in malignancy.
    Ford HL; Thompson EW
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):113-5. PubMed ID: 20544376
    [No Abstract]   [Full Text] [Related]  

  • 12. Matrix metalloproteinase-induced epithelial-mesenchymal transition: tumor progression at Snail's pace.
    Przybylo JA; Radisky DC
    Int J Biochem Cell Biol; 2007; 39(6):1082-8. PubMed ID: 17416542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.
    Radisky ES; Raeeszadeh-Sarmazdeh M; Radisky DC
    J Cell Biochem; 2017 Nov; 118(11):3531-3548. PubMed ID: 28585723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-induced malignancy in mammary epithelial cells.
    Stallings-Mann M; Radisky D
    Cells Tissues Organs; 2007; 185(1-3):104-10. PubMed ID: 17587815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathology of EMT in mouse mammary tumorigenesis.
    Cardiff RD
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):225-33. PubMed ID: 20521088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-induced fibrosis and malignancy in breast and lung.
    Radisky DC; Przybylo JA
    Proc Am Thorac Soc; 2008 Apr; 5(3):316-22. PubMed ID: 18403326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncanonical TGF-β signaling during mammary tumorigenesis.
    Parvani JG; Taylor MA; Schiemann WP
    J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):127-46. PubMed ID: 21448580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2.
    Chakrabarti R; Hwang J; Andres Blanco M; Wei Y; Lukačišin M; Romano RA; Smalley K; Liu S; Yang Q; Ibrahim T; Mercatali L; Amadori D; Haffty BG; Sinha S; Kang Y
    Nat Cell Biol; 2012 Nov; 14(11):1212-22. PubMed ID: 23086238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
    Coussens LM; Fingleton B; Matrisian LM
    Science; 2002 Mar; 295(5564):2387-92. PubMed ID: 11923519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT).
    Blavier L; Lazaryev A; Shi XH; Dorey FJ; Shackleford GM; DeClerck YA
    Cancer Biol Ther; 2010 Jul; 10(2):198-208. PubMed ID: 20534975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.